AAPL stock · BMRN stock

AAPL vs BMRN · P/E 39, rev $416.16B vs P/E 40, rev $2.85B

Apple Inc (AAPL) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.

Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Tim Cook.

Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.

Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.

Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.

AAPL currently screens at market cap $3.83T and trailing P/E 39.2. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.

Not investment advice. Open the AAPL and BMRN stock pages for the full models.

Not investment advice.

Popular Stock Comparisons